Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael F Picco

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Crohn'S & Colitis 360|June 16, 2025
Pathologic Rate of Cancer After Surgery for Dysplasia Detected on Chromoendoscopy for Inflammatory Bowel DiseaseTalal Dahab, Luca Stocchi, Amit Merchea, et al.
Inflammatory Bowel Diseases|July 13, 2024
Metformin Is Associated With Improved Inflammatory Bowel Disease Outcomes in Patients With Type 2 Diabetes Mellitus: A Propensity-Matched Cohort StudyJessica C Petrov, Aakash A Desai, Gursimran S Kochhar, et al.
Crohn'S & Colitis 360|February 13, 2023
Oral Contraceptive Pills Are an Effective Method of Preventing Pregnancy in Women With Crohn's DiseaseNader D Daoud, Hassan Ghoz, Rachel Cannon, et al.
Annals of Gastroenterology|September 12, 2025
Tertiary referral for double balloon enteroscopy in small bowel Crohn's disease: a retrospective assessment of diagnostic impactDaniela Fluxa, Hasan Saleh, Christian Karime, et al.
The American Journal of Gastroenterology|May 8, 2024
Utility of a Third Heplisav-B Dose in Patients With Inflammatory Bowel Disease Without Immunity After 2-Dose Heplisav-B VaccinationChristian Karime, Cecily N Black, Pedro Cortes, et al.
Inflammatory Bowel Diseases|June 15, 2007
Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot studyKim L Isaacs, Robert S Sandler, Maria Abreu, et al.
BMJ Open Gastroenterology|October 13, 2023
Polygenic risk score predicts risk of primary sclerosing cholangitis in inflammatory bowel diseaseMing-Hsi Wang, Jessica J Friton, Laura E Raffals, et al.
Inflammatory Bowel Diseases|March 16, 2021
Novel Genetic Variant Predicts Surgical Recurrence Risk in Crohn's Disease PatientsMing-Hsi Wang, Jessica J Friton, Laura E Raffals, et al.
Journal of Crohn'S & Colitis|January 29, 2019
Novel Genetic Risk Variants Can Predict Anti-TNF Agent Response in Patients With Inflammatory Bowel DiseaseMing-Hsi Wang, Jessica J Friton, Laura E Raffals, et al.
Inflammatory Bowel Diseases|October 19, 2019
Unique Phenotypic Characteristics and Clinical Course in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Multicenter US ExperienceMing-Hsi Wang, Omar Y Mousa, Jessica J Friton, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Crohn'S & Colitis 360|June 16, 2025
Pathologic Rate of Cancer After Surgery for Dysplasia Detected on Chromoendoscopy for Inflammatory Bowel DiseaseTalal Dahab, Luca Stocchi, Amit Merchea, et al.
Inflammatory Bowel Diseases|July 13, 2024
Metformin Is Associated With Improved Inflammatory Bowel Disease Outcomes in Patients With Type 2 Diabetes Mellitus: A Propensity-Matched Cohort StudyJessica C Petrov, Aakash A Desai, Gursimran S Kochhar, et al.
Crohn'S & Colitis 360|February 13, 2023
Oral Contraceptive Pills Are an Effective Method of Preventing Pregnancy in Women With Crohn's DiseaseNader D Daoud, Hassan Ghoz, Rachel Cannon, et al.
Annals of Gastroenterology|September 12, 2025
Tertiary referral for double balloon enteroscopy in small bowel Crohn's disease: a retrospective assessment of diagnostic impactDaniela Fluxa, Hasan Saleh, Christian Karime, et al.
The American Journal of Gastroenterology|May 8, 2024
Utility of a Third Heplisav-B Dose in Patients With Inflammatory Bowel Disease Without Immunity After 2-Dose Heplisav-B VaccinationChristian Karime, Cecily N Black, Pedro Cortes, et al.
Inflammatory Bowel Diseases|June 15, 2007
Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot studyKim L Isaacs, Robert S Sandler, Maria Abreu, et al.
BMJ Open Gastroenterology|October 13, 2023
Polygenic risk score predicts risk of primary sclerosing cholangitis in inflammatory bowel diseaseMing-Hsi Wang, Jessica J Friton, Laura E Raffals, et al.
Inflammatory Bowel Diseases|March 16, 2021
Novel Genetic Variant Predicts Surgical Recurrence Risk in Crohn's Disease PatientsMing-Hsi Wang, Jessica J Friton, Laura E Raffals, et al.
Journal of Crohn'S & Colitis|January 29, 2019
Novel Genetic Risk Variants Can Predict Anti-TNF Agent Response in Patients With Inflammatory Bowel DiseaseMing-Hsi Wang, Jessica J Friton, Laura E Raffals, et al.
Inflammatory Bowel Diseases|October 19, 2019
Unique Phenotypic Characteristics and Clinical Course in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Multicenter US ExperienceMing-Hsi Wang, Omar Y Mousa, Jessica J Friton, et al.
Pageof 7